Tag Archive for: artificial intelligence

Biden is also ordering his administration to report on progress they are making to erase gender gaps in research and to study how to use artificial intelligence to improve women’s health research, according to an administration document summarizing the order.

At this year’s SXSW, amid the whirlwind of tech and culture, a clear yearning pulsed through its presentations and panels: a quest for authenticity, humanity, and a raw, unfiltered sense of realness. This wasn’t just a fleeting theme, but the core of what people are seeking today — in life, in technology, and yes, with brands. The following are a few key observations as a brand and design leader from the floor.

The collaboration will include the development of computational pathology algorithms powered by AI and machine learning (ML) that connect baseline pathology data, such as molecular tumor profiles, with clinical data, such as patient outcomes, to enable better patient identification, stratification, and selection for clinical trials.

Artificial intelligence (AI) surely stands at the forefront of one of the most transformative periods in the pharmaceutical industry. Its rapid drug discovery capabilities and potential for personalized patient care mark AI as a revolutionary influence in reshaping the pharmaceutical industry. Central to this transformation is natural language processing (NLP).

Artificial intelligence is well beyond a buzz word. Agencies can’t talk the talk anymore; they need to understand how the technology can apply across their entire business.

The $100-million facility is expected to employ over 1,500 employees and will be used to enhance its drug development through the use of digital technologies and artificial intelligence.

Med Ad News spoke with Marcia Goddard on Day Three of her new role as chief creative officer at RevHealth, and she was definitely energized and excited about the transformation RevHealth has been undergoing – a new branding and vision, and changes to the leadership team.

It was last year’s hottest topic, and this year it is sure to be at the top of the list. It dominates conversations, and it sure does dominate my inbox. Artificial intelligence.

By nearly unanimous consent artificial intelligence reached an inflection point for pharma marketers in 2023. The question of how best to take advantage of this new tool to support brands and help patients, though, remains to be seen.

In 2024, the industry must acknowledge the interconnected impact of the Inflation Reduction Act (IRA), growing AI and technology usage, and evolving smart data, as these factors create a ripple effect. How market access responds to these effects will impact sales and marketing. Effectively addressing these impacts lies at the heart of industry reform.